Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ebola
Biotech
Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO
Officials are planning to study Mapp Biopharmaceutical’s MBP134 and Gilead Sciences’ remdesivir, which saw widespread use against COVID-19.
Eric Sagonowsky
Jun 24, 2026 3:03pm
US taps small biotech for experimental Ebola treatment
May 20, 2026 7:18pm
Pfizer ‘comfortable’ joining fights with hantavirus, Ebola: exec
May 20, 2026 5:05am
An antiviral once tested for COVID works in mice with Ebola
Oct 3, 2023 4:10pm
BARDA backs Satio's development of a patch-based Ebola test
Aug 21, 2023 10:57am
Inovio hopes Ebola booster data can boost fortunes, too
Feb 2, 2023 9:50am
